Goodwin is presenting a two-part publication series covering life sciences trends involving license deals, M&A, and financing for Greater China’s ...

Experts in the neuropsychiatry drug development space say targeting the right patient population will be key for success in ...

His name is familiar to every student who enters the Behrakis Health Science Center, which for two decades has served as a ...

The annual meeting of the American College of Gastroenterology was held from Oct. 25 to 30 in Philadelphia and attracted ...

The first time Johnson & Johnson faced a lawsuit due to its talc-based baby powder causing cancer was way back in 1999. Since ...

With the rise in global counterfeiting operations, stakeholders need to be aware of their responsibility when it comes to pharmaceutical goods and their legitimacy. Companies can make this task easier ...

Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...

Healthcare systems were pushed to breaking point, and demonstrated how critical smart investment and regular and reliable funding are to their resilience. And years of investment in medicines and ...

Johnson & Johnson‘s Darzalex hit the primary endpoint in Phase 3 early-stage ... Gilead Sciences’ Veklury sales grew 9% to ...

Woody Johnson, Linda McMahon, Herschel Walker, and Dana White top the list. The post The Sports Figures Who Could Be in the ...

Johnson & Johnson announced that the China National Medical Products Administration has approved Teclistamab Injection as a ...

Biotech and pharmaceutical companies are well known for raising capital through initial public offerings, or IPOs. Between ...